← Eichor
Study identifier: NCT07363694 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Condition: Moderate to Severe Chronic Obstructive Pulmonary Disease  ·  Sponsor: Pfizer

PhasePhase 2/Phase 3
Planned participants1156
Who can joinAll sexes, 35 Years to 80 Years
Healthy volunteersNo

About this study

The purpose of this clinical trial is to learn about the effects and safety of the study medicine PF-07275315 for the potential treatment of COPD. COPD is a condition that makes it difficult to breathe, which negatively impacts the quality of life and functioning of people who are affected. This study is seeking participants who: * Are 35 to 80 years old * Have had moderate-to-severe COPD for at least 12 months * Have a documented history of at least 2 moderate or severe exacerbations within the last 12 months * Have been continuously taking their regular maintenance treatment(s) for COPD over at least 6 months at a stable dose for 3 months All participants will receive PF-07275315 or a placebo. A placebo does not have any medicine in it but looks just like the medicine being studied. PF-07275315 or placebo will be given as multiple shots in the clinic over the course of 24 weeks for the Phase 2 part and 52 weeks for the Phase 3 part. We will compare the results of people receiving PF-07275315 to those of the people who do not. This will help us determine if PF-07275315 is safe and effective. Participants who will be involved in the Phase 2 part of the study for about 40 weeks. During this time, they will have 11 visits at the study clinic. Participants who will be involved in the Phase 3 part of the study for about 68 weeks. During this time, they will have 18 visits at the study clinic.

This description comes directly from the study's public registry record.

Talk to the study team

Pfizer CT.gov Call Center  ·  1-800-718-1021  ·  ClinicalTrials.gov_Inquiries@pfizer.com

Always discuss trial participation with your own doctor first.

Locations (103)

University of Alabama at Birmingham Lung Health CenterBirmingham, Alabama, United StatesRecruiting
SEC Clinical ResearchDothan, Alabama, United StatesRecruiting
Pulmonary Associates of Mobile, P.C.Mobile, Alabama, United StatesRecruiting
Chandler Clinical TrialsChandler, Arizona, United StatesNot Yet Recruiting
Pulmonary Associates, PAPhoenix, Arizona, United StatesRecruiting
IMAX Clinical TrialsLa Palma, California, United StatesRecruiting
NewportNativeMD, Inc.Newport Beach, California, United StatesRecruiting
California Medical Research AssociatesNorthridge, California, United StatesRecruiting
Institute of HealthCare Assessment d/b/a Apex Clinical ResearchSan Diego, California, United StatesRecruiting
Finlay Medical ResearchGreenacres City, Florida, United StatesRecruiting
Clinical Research Specialists LLCKissimmee, Florida, United StatesRecruiting
Advanced Pulmonary Research InstituteLoxahatchee Groves, Florida, United StatesRecruiting

+ 91 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07363694